If the strong presence of SSTR2 in PA is shown to have a clinical meaning, an SSA treatment could potentially be used to prevent tumor progression in patients with serious comorbidities that pose a high risk for general anesthesia and/or surgery or in cases where a conservative, non-invasive therapy is preferable. Here, SSTR2 is linked to neoplasm.